Inventor
CANTOR HARVEY
US9 patents
⚠️ This page may combine multiple inventors who share the name “CANTOR HARVEY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DANA FARBER CANCER INST INC
8 patentsUS10548957B2Feb 4, 2020
Targeted expansion of Qa-1-peptide-specific regulatory CD8 T cells to ameliorate arthritis
DANA FARBER CANCER INST INC6 citations80
US10596195B2Mar 24, 2020
Discovery of regulatory T cells programmed to suppress an immune response
DANA FARBER CANCER INST INC3 citations68
US6472170B1Oct 29, 2002
BCL-Xy, a novel BCL-X isoform, and uses related thereto
DANA FARBER CANCER INST INC2 citations59
US11590213B2Feb 28, 2023
Targeted expansion of Qa-1-peptide-specific regulatory CD8 T cells to ameliorate arthritis
DANA FARBER CANCER INST INC0 citations58
US12202904B2Jan 21, 2025
IL-23R antagonists to reprogram intratumoral T regulatory cells into effector cells
DANA FARBER CANCER INST INC0 citations56
US11591403B2Feb 28, 2023
IL-23R antagonists to reprogram intratumoral T regulatory cells into effector cells
DANA FARBER CANCER INST INC0 citations56
US11371989B2Jun 28, 2022
Intracellular osteopontin regulates the lineage commitment of lymphoid subsets
DANA FARBER CANCER INST INC0 citations56
US7160986B2Jan 9, 2007
BCL-xγ, a novel BCL-x isoform, and uses related thereto
DANA FARBER CANCER INST INC0 citations48